Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
Eliquis3.72B31.35%
Opdivo2.08B17.51%
Revlimid1.67B14.07%
Other1.11B9.31%
Pomalyst/Imnovid865M7.29%
Orencia798M6.73%
Yervoy583M4.91%
Sprycel374M3.15%
Reblozyl354M2.98%
Other Growth products319M2.69%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States31.56B70.11%
International12.75B28.33%
Other699M1.55%
